A comprehensive view of Akouos Inc. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Eli Lilly's Akouos reports positive Phase 1/2 clinical trial data for an investigational gene therapy for genetic hearing loss to be presented at the Assn. for Research in Otolaryngology 2024 MidWinter meeting
Published:
January 23, 2024
by Eli Lilly & Co.
|
Ask us about our R&D/Patents market view